Sandra Day O’Connor’s Battle With Dementia Detailed in New Biography

Evan Thomas's 2019 biography "First: Sandra Day O'Connor" provides an intimate chronicle of how dementia reshaped the life of America's first female...

Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.

Sandra day sits at the center of this dementia and brain health question.

Evan Thomas’s 2019 biography “First: Sandra Day O’Connor” provides an intimate chronicle of how dementia reshaped the life of America’s first female Supreme Court Justice. The book reveals that O’Connor’s cognitive decline began years before her public announcement, with a particularly telling moment occurring in September 2013 at the University of Colorado Law School, when she asked colleagues backstage, “What am I speaking about?” just moments before delivering a lecture.

This early warning sign foreshadowed a diagnosis that would ultimately define her final years—a private battle she fought while still serving on the bench before finally going public on October 23, 2018, when she announced she had “the beginning stages of dementia, probably Alzheimer’s disease.” What makes Thomas’s biography particularly significant is that it documents not just the clinical progression of her illness, but also the human reality of one of the nation’s most accomplished jurists confronting cognitive loss. At 88 years old when she made her public announcement, O’Connor had already received a private Alzheimer’s diagnosis before February 2016, when Thomas conducted his interviews for the book. Her declining cognition during those interviews meant she was unable to serve as a substantial source for her own biography—a poignant detail that underscores how quickly the disease can erode even the sharpest minds.

Table of Contents

When a Supreme Court Justice Goes Public: Sandra Day O’Connor’s October 2018 Announcement

On October 23, 2018, O’Connor released a statement that sent shockwaves through legal and medical communities alike. She had decided to publicly disclose her dementia diagnosis and announce her withdrawal from public life. This announcement came just two months before the publication of Thomas’s biography, which would provide readers with the fuller picture of what she had been experiencing privately. By this time, she had already stepped back significantly from her civic engagement work, particularly her efforts to promote civics education—a cause she had championed for years after leaving the bench in 2006. The timing of her public disclosure is medically significant because it occurred roughly four years after that telling 2013 incident at the University of Colorado, suggesting she had lived with early symptoms for an extended period before seeking a formal diagnosis.

This lag between symptom emergence and diagnosis is common in Alzheimer’s disease, as people often attribute early memory problems to normal aging or stress. For O’Connor, a woman of exceptional intellect and discipline, recognizing and acknowledging decline likely required considerable introspection and perhaps denial before accepting the reality of her condition. What distinguishes O’Connor’s announcement from many dementia diagnoses is that she made the decision to step away from the public eye entirely rather than attempt to manage her role while cognitively declining. This choice reflected both her personal values and practical recognition of what her disease would require. Unlike some public figures who attempt to maintain their positions while living with dementia, O’Connor’s withdrawal was clean and complete—no appearances, no public statements, no gradual fade from view.

When a Supreme Court Justice Goes Public: Sandra Day O'Connor's October 2018 Announcement

The 2013 Incident: Early Warning Signs of Sandra Day O’Connor’s Cognitive Decline

The university of Colorado Law School incident stands as the earliest well-documented marker of O’Connor’s cognitive troubles. When she asked “What am I speaking about?” backstage, friends and colleagues had to step in and brief her on the topic of her own lecture. For someone of O’Connor’s background—a woman who had argued cases before the Supreme Court and served as a Justice for 24 years—such a moment represented a dramatic departure from her normal functioning. Yet she persisted, delivering her lecture with support from those around her, suggesting she was trying to maintain her public engagement despite knowing something was wrong. The five-year gap between this 2013 incident and her 2018 public announcement reveals how insidiously Alzheimer’s disease progresses.

The disease doesn’t announce itself with a single catastrophic event; instead, it advances through subtle cognitive stumbles, misplaced words, forgotten details, and moments of confusion that can be explained away or hidden. By the time O’Connor sought formal diagnosis and went public in 2018, neurological damage had likely been accumulating for years. When Evan Thomas interviewed her in February 2016, her condition had already progressed to the point where she couldn’t meaningfully contribute to her own biography—a limitation Thomas had to work around in writing the book. This progression pattern is typical of Alzheimer’s disease, which can silently damage the brain for a decade or more before symptoms become noticeable. For high-functioning individuals like O’Connor, early cognitive changes might manifest as difficulty with novel situations, temporary word-finding problems, or the need to rely more heavily on written notes—changes that busy professionals might easily rationalize as part of normal aging or stress. The disease’s gradual nature means early intervention and honest assessment with healthcare providers become crucial, yet these conversations are often delayed precisely because the changes feel subtle and attributable to other causes.

Alzheimer’s Prevalence by Age65-743%75-849%85-8919%90-9424%95+32%Source: Alzheimer’s Association

The Caregiver’s Perspective: Sandra Day O’Connor’s 28-Year Journey With Her Husband’s Alzheimer’s Disease

Long before O’Connor faced her own Alzheimer’s diagnosis, she had lived intimately with the disease through her husband, John Jay O’Connor. He received his diagnosis in 1990, more than a quarter-century before Sandra’s announcement. What makes their story particularly poignant is that Sandra continued to serve on the Supreme Court for another 16 years after her husband’s diagnosis, meaning she was simultaneously one of the nation’s most powerful jurists and a full-time dementia caregiver. John Jay lived approximately two decades after his diagnosis, requiring increasingly intensive care as the disease progressed. Sandra’s experience as a caregiver provided her with frontline knowledge of what Alzheimer’s entails—the cognitive decline, the behavioral changes, the loss of independence, and the emotional toll on both patient and family. She witnessed firsthand how the disease unfolds over years, how it transforms a person you know completely into someone who may no longer recognize you, and the exhaustion that comes with providing 24-hour care.

When she was finally diagnosed herself, O’Connor already understood with terrible clarity what her future likely held. There’s a particular cruelty in a dementia diagnosis when the person already knows the trajectory from intimate experience with a loved one’s illness. John Jay’s journey also illustrates a critical reality about Alzheimer’s disease: it’s a family illness, not just an individual condition. The caregiver burden extends far beyond the person diagnosed. For O’Connor, managing both a Supreme Court career and her husband’s care required extraordinary personal resources, support systems, and sacrifice. Her experience underscores why dementia care planning must address not just the patient but the entire family system—something many families discover too late when they’re already overwhelmed by care demands.

The Caregiver's Perspective: Sandra Day O'Connor's 28-Year Journey With Her Husband's Alzheimer's Disease

What the Biography Reveals: The Private Progression Documented in Evan Thomas’s Book

When Evan Thomas set out to write “First: Sandra Day O’Connor,” published on March 19, 2019, he was working with a subject whose cognitive capacity was already compromised. O’Connor had received her Alzheimer’s diagnosis sometime before her 2018 public announcement, and by February 2016—when Thomas conducted his interviews—she was unable to be a meaningful source for her own life story. This fact, documented in the biography itself, provides a stark illustration of how the disease had progressed. Thomas had to assemble her story largely through interviews with family, friends, and colleagues rather than relying on O’Connor’s own recollections and perspectives. The biography documents the emotional and psychological dimensions of O’Connor’s experience that clinical accounts cannot capture. It reveals her frustration with cognitive changes, her determination to maintain dignity despite her illness, and the support of her family as she confronted what lay ahead.

For readers interested in understanding how a prominent public figure experiences dementia—stripped of the medical jargon and reduced to human experience—Thomas’s account provides valuable insight. The book captures both the personal horror of losing one’s cognitive abilities and the resilience required to accept such losses gracefully. What makes this biography particularly valuable for those dealing with dementia in their own families is that it humanizes the disease. O’Connor wasn’t just a Justice facing memory loss; she was a woman who had built her identity around intellectual achievement, who had trained her mind to precision and clarity for nearly a century, now watching those abilities slip away. Her documented experience resonates across socioeconomic and educational divides because the fundamental experience of cognitive loss—that disorientation, that sense of self eroding—transcends status or achievement. A cleaner, a professor, and a Supreme Court Justice all face the same neurological disease and similar psychological struggles when Alzheimer’s takes hold.

Understanding Progressive Alzheimer’s: What Sandra Day O’Connor’s Timeline Teaches About Disease Progression

The documented timeline of Sandra Day O’Connor’s illness—from the 2013 incident through her 2018 diagnosis to her death on December 1, 2023, at age 93—spans ten years of observable cognitive change. This extended timeline is consistent with what neurologists observe in Alzheimer’s disease. The pathology of the disease, characterized by the accumulation of amyloid plaques and tau tangles in the brain, can be silently damaging neural tissue for years before behavioral symptoms appear. By the time someone receives a formal diagnosis, significant brain damage has often already occurred. O’Connor’s case illustrates an important limitation of our current diagnostic capabilities: we can only identify Alzheimer’s disease through its behavioral and cognitive manifestations, not through the underlying pathology that causes them. The actual disease process was likely underway during her years on the Supreme Court, decades before any external signs appeared.

Only in recent years have biomarkers been developed that might identify amyloid accumulation before symptoms emerge, but these tests were not available during O’Connor’s early cognitive changes. This means that most people diagnosed with Alzheimer’s today are in a similar situation—by the time they receive a diagnosis, a substantial portion of neuronal damage has already occurred. The progression from early cognitive lapses in 2013 to her death ten years later also demonstrates that Alzheimer’s is a disease of variable progression. For O’Connor, a decade elapsed from early symptoms to death, with most of those final years spent in increasingly advanced dementia requiring full-time care. Some people live longer after diagnosis, while others progress more rapidly. This variability means that family members and caregivers cannot rely on population averages to predict individual outcomes. The only certainty is that the disease progresses, eventually affecting virtually every cognitive function, and ultimately compromises the body’s basic regulatory systems.

Understanding Progressive Alzheimer's: What Sandra Day O'Connor's Timeline Teaches About Disease Progression

The Burden of Public Loss: Sandra Day O’Connor’s High-Profile Dementia Diagnosis

One element that distinguishes O’Connor’s experience from many dementia diagnoses is the magnitude of public attention. As the first female Supreme Court Justice, her cognitive decline was not a private family matter but a matter of public record and national discussion. When she announced her diagnosis, it became a news story not because her disease was unique—thousands of Americans receive Alzheimer’s diagnoses every week—but because of who she was. This spotlight had both advantages and disadvantages. The public nature of O’Connor’s diagnosis brought increased attention to dementia and Alzheimer’s disease in general, potentially normalizing discussions about cognitive decline and caregiving in ways that benefit other families. Her willingness to go public created space for conversation about what dementia looks like in accomplished, successful people—not just in the very elderly or institutionalized, but in professionals, leaders, and active members of society.

However, the same publicity meant her decline became part of the national conversation in ways she might not have chosen. Privacy is often one of the final refuges for people with progressive dementia, and O’Connor’s status made that privacy impossible to maintain. Another limitation of being a public figure with dementia is the potential for mischaracterization or oversimplification. The media narrative sometimes reduced her complex experience to a simple tragedy of decline, when the reality of living with Alzheimer’s is far more nuanced. Families dealing with dementia in private settings can at least control who knows about their situation and how information is shared. O’Connor had no such control, and every update about her condition potentially became public knowledge.

Legacy and Lessons: What Sandra Day O’Connor’s Story Teaches About Dementia Care

Sandra Day O’Connor died on December 1, 2023, at age 93 from complications related to advanced dementia, probably Alzheimer’s, and a respiratory illness. Her death marked the end of a long decline but also the end of a remarkable public conversation about dementia that her diagnosis had initiated. By going public with her condition, O’Connor helped shift cultural understanding of Alzheimer’s from something that happens to “other people” to a disease that can affect anyone, regardless of intellect, achievement, or status. Evan Thomas’s biography ensures that her experience and her insights remain available to future generations dealing with similar challenges.

The enduring value of O’Connor’s documented journey is that it illustrates the full arc of dementia—from the barely noticeable early signs, through the diagnosis and progressive loss of function, to the ultimate complications that end life. Her story also emphasizes the importance of family support, the reality of caregiver burden, and the necessity of planning for cognitive decline. For families currently facing a dementia diagnosis, O’Connor’s example demonstrates that cognitive loss, while profound and tragic, doesn’t erase a person’s fundamental dignity or the possibility of remaining engaged with life and loved ones even as the disease progresses. Her decision to step away from public life was presented not as shame or defeat, but as a clear-eyed assessment of what her condition required—a model of acceptance that many families find instructive as they navigate their own dementia journeys.

Conclusion

Sandra Day O’Connor’s battle with Alzheimer’s disease, as documented in Evan Thomas’s 2019 biography “First: Sandra Day O’Connor,” reveals both the clinical reality and the deeply human experience of progressive dementia. From the early warning sign in 2013 when she couldn’t remember her lecture topic, through her 2018 public announcement at age 88, to her death in 2023, her documented journey illustrates how Alzheimer’s silently progresses, how it touches families across all socioeconomic backgrounds, and how a person of extraordinary achievement can face cognitive decline with dignity.

The biography makes clear that her struggle began years before the world knew about it, a pattern consistent with how Alzheimer’s operates in the brain long before symptoms become apparent. For those navigating dementia in their own families, O’Connor’s story offers important lessons: early warning signs should not be dismissed, family systems will be transformed by the diagnosis, caregiving is a profound responsibility that deserves support, and accepting cognitive limitations becomes a necessary part of living with this disease. Her willingness to make her journey public, through Thomas’s biography and her own statements, has created a valuable resource for understanding what dementia actually means for real people facing real challenges in their lives.

You Might Also Like

Browse more: Activities | Alzheimer’s | Aphasia | Blog/News | Books

For more, see National Institute on Aging.

Related Posts